Lexeo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.4%.

Top 25 shareholders own 102.24% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.4%	Janus Henderson Group plc	3,763,195	US$24.3m	18.9%	0.01%
8.36%	Longitude Capital Management Co., LLC	2,765,381	US$17.9m	0%	3.07%
8.24%	Citadel Advisors LLC	2,723,363	US$17.6m	6.44%	0.02%
7.86%	Adage Capital Management, L.P.	2,597,736	US$16.8m	0%	0.03%
7.58%	D1 Capital Partners L.P.	2,506,607	US$16.2m	0%	0.27%
7.12%	Omega Fund Management, LLC	2,355,904	US$15.2m	0%	7.63%
5.61%	Eventide Asset Management, LLC	1,855,986	US$12.0m	-44.9%	0.19%
4.93%	BlackRock, Inc.	1,630,287	US$10.5m	106%	no data
4.04%	Ronald Crystal	1,337,465	US$8.7m	0%	no data
3.78%	Frazier Life Sciences Management, LP	1,250,786	US$8.1m	0%	0.32%
3.5%	Blackstone Alternative Asset Management L.P.	1,158,617	US$7.5m	43.8%	1.45%
3.43%	PBM Capital Group LLC	1,132,692	US$7.3m	0%	60.03%
3.39%	Novo Holdings A/S	1,122,581	US$7.3m	-22.6%	no data
2.85%	Lundbeckfonden BioCapital	942,671	US$6.1m	-48.7%	0.09%
2.62%	The Vanguard Group, Inc.	864,711	US$5.6m	37.3%	no data
2.58%	Woodline Partners LP	851,961	US$5.5m	3.38%	0.04%
2.57%	Vestal Point Capital, LP	850,000	US$5.5m	1.19%	0.43%
2.35%	Verition Fund Management LLC	777,320	US$5.0m	84.5%	0.04%
2.2%	Braidwell LP	728,777	US$4.7m	-47.3%	0.2%
1.82%	Artal Group S.A.	603,435	US$3.9m	0%	0.1%
1.67%	Geode Capital Management, LLC	553,247	US$3.6m	86.5%	no data
1.65%	RA Capital Management, L.P.	546,554	US$3.5m	-18.8%	0.04%
1.12%	Point72 Asset Management, L.P.	370,407	US$2.4m	0%	0.01%
0.79%	Laurion Capital Management LP	260,228	US$1.7m	-42.6%	0.1%
0.78%	Ikarian Capital, LLC	257,216	US$1.7m	0%	0.46%